Work

Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple-negative breast cancer patients

Year: 2024

Type: article

Study design: Observational Study

Source: Endocrine Related Cancer

DOI: 10.1530/erc-24-0120

Authors: Marta Villanova, Sara M Tolaney, Le Min

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402276774

FWCI: 0.619

Cites:

Cited by: 4

Related to: 10